These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 949523)

  • 1. Treatment of rat fibrosarcoma by radiotherapy plus immune adjuvant.
    Moroson H; Schechter M
    Biomedicine; 1976 May; 25(3):97-100. PubMed ID: 949523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
    Collins AL; Song CW
    Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
    Mukai M; Ando K; Koike S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined effect of the topical administration of OK-432 with radiation on the C3H mouse fibrosarcoma (NFSa)--TCD50 and the mechanism of action].
    Mukai M; Ando K; Koike S; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3432-5. PubMed ID: 3789754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BCG and C. parvum preparations for adjuvant contact therapy of a rat sarcoma.
    Wilmott N; Pimm MV; Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():39-43. PubMed ID: 608529
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation.
    Douple EB
    Natl Cancer Inst Monogr; 1977 Dec; 46():179-84. PubMed ID: 206836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BCG and C. parvum on in vivo Listeria clearance and tumor growth. Comparative studies in normal and congenitally athymic (nude) mice.
    Ruitenberg EJ; Steerenberg PA; van Noorle Jansen LM
    Dev Biol Stand; 1977 Apr 13-15; 38():103-7. PubMed ID: 415917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposals for quality control methods of bacterial vaccines for immunostimulation. III. Effect of BCG and C. parvum on in vivo Listeria clearance and tumor growth.
    Ruitenberg EJ; Steerenberg PA; van Noorle Jansen LM
    Dev Biol Stand; 1977 Apr 13-15; 38():97-101. PubMed ID: 415924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
    Shu SY; Chou T; Sakai K
    J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
    Keller R
    J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M; Yamashita T; Suit HD; Gerweck LE
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
    Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
    Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
    Ibraheim EH; El Kappany H; Nigam VN; Brailovsky CA; Madarnas P; Elhilali MM
    Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nonspecific stimulators on body resistance to tumor growth].
    Bulbuk GA
    Patol Fiziol Eksp Ter; 1983; (5):66-9. PubMed ID: 6646836
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination].
    Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the anti-tumor activity of direct current--an effective adjuvant therapy in irradiation].
    Ito H; Hashimoto S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1405-11. PubMed ID: 2786377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.